Markets Gone Wild

The Benefits of Crofelemer for Chronic Refractory Diarrhea Abstracts Available for Investigator-Initiated Studies at ACG 2024 It is estimated that 10-15% of people in the United States suffer from Irritable Bowel Syndrome (IBS), a condition that can cause chronic refractory diarrhea. In response to this need, Jaguar Health, Inc. and Napo Pharmaceuticals have developed crofelemer,…

Suffered a Loss on Your Newmont Corporation Investment? Here’s What You Need to Know Newmont Corporation (NYSE: NEM), one of the world’s leading gold mining companies, has found itself in the midst of a securities class action lawsuit. If you’ve been following the financial news, you may have heard about this development and are wondering…

Regeneron Pharmaceuticals, Inc. Investor Alert: Loss on Investment Recovery Are you an investor who has suffered a loss on your Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) investment? If so, you may be eligible to seek recovery under the federal securities laws. Joseph E. Levi, Esq., is available to assist you in exploring your options. Understanding Securities Lawsuits…

ARKO Corp. (ARKO) Quarterly Loss: A Closer Look In a recent financial report, ARKO Corp. (ARKO) announced a quarterly loss of $0.03 per share, falling short of the Zacks Consensus Estimate of $0.04. This disappointing result represents a significant shift from the break-even earnings per share reported during the same quarter last year. Impact on…

The Shiny New Kid on the ETF Block: Invesco NASDAQ Next Gen 100 ETF (QQQJ) Welcome, dear investor, to the exciting world of exchange-traded funds (ETFs)! On October 13, 2020, a new player entered the ETF scene, and its name is Invesco NASDAQ Next Gen 100 ETF, ticker symbol QQQJ. What’s the Deal with QQQJ?…